Carlo A. Marra, Ph.D. - Publications

Affiliations: 
2004 University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Public Health

137/320 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Lam SJ, Lynd LD, Marra CA. Pharmacists' Satisfaction with Work and Working Conditions in New Zealand-An Updated Survey and a Comparison to Canada. Pharmacy (Basel, Switzerland). 11. PMID 36827659 DOI: 10.3390/pharmacy11010021  0.442
2020 Yamoah L, Dragojlovic N, Smith A, Lynd LD, Marra CA. Evaluating New Zealanders' Values for Drug Coverage Decision Making: Trade-Offs between Treatments for Rare and Common Conditions. Pharmacoeconomics. PMID 33150565 DOI: 10.1007/s40273-020-00974-8  0.469
2020 Tsao NW, Salmasi S, Li K, Nakagawa B, Lynd LD, Marra CA. Pharmacists' perceptions of their working conditions and the factors influencing this: Results from 5 Canadian provinces. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 153: 161-169. PMID 32528600 DOI: 10.1177/1715163520915230  0.493
2020 Raymakers A, Sin DD, Sadatsafavi M, FitzGerald JM, Marra CA, Lynd LD. Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study. Respiratory Research. 21: 118. PMID 32429927 DOI: 10.1186/S12931-020-01344-W  0.515
2020 Raymakers AJN, Sadatsafavi M, Sin DD, FitzGerald JM, Marra CA, Lynd LD. Avoiding immortal time bias in observational studies. The European Respiratory Journal. 55. PMID 32198270 DOI: 10.1183/13993003.02494-2019  0.493
2019 Chan SJ, Stamp LK, Liebergreen N, Ndukwe H, Marra C, Treharne GJ. Tapering Biologic Therapy for Rheumatoid Arthritis: A Qualitative Study of Patient Perspectives. The Patient. PMID 31802391 DOI: 10.1007/S40271-019-00403-9  0.32
2019 McCormick N, Marra CA, Sadatsafavi M, Aviña-Zubieta JA. Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study. Seminars in Arthritis and Rheumatism. PMID 31358362 DOI: 10.1016/J.Semarthrit.2019.06.010  0.307
2019 Salmasi S, Tsao NW, Li K, Shaske JN, Marra CA, Lynd LD. Characterization of pharmacist-based medication management services in a community pharmacy. Research in Social & Administrative Pharmacy : Rsap. PMID 31060791 DOI: 10.1016/J.Sapharm.2019.04.051  0.525
2019 Raymakers AJN, Sadatsafavi M, Sin DD, FitzGerald JM, Marra CA, Lynd LD. Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study. The European Respiratory Journal. PMID 30956205 DOI: 10.1183/13993003.01257-2018  0.513
2019 Rizzardo S, Bansback N, Dragojlovic N, Douglas C, Li KH, Mitton C, Marra C, Blanis L, Lynd LD. Evaluating Canadians' Values for Drug Coverage Decision Making. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 362-369. PMID 30832975 DOI: 10.1016/J.Jval.2018.08.008  0.535
2018 Lynd LD, Henrich NJ, Hategeka C, Marra CA, Mittmann N, Evans C, Traboulsee AL. Perspectives of Patients with Multiple Sclerosis on Drug Treatment: A Qualitative Study. International Journal of Ms Care. 20: 269-277. PMID 30568564 DOI: 10.7224/1537-2073.2017-109  0.524
2018 Khakban A, Mohammadi T, Lynd LD, Mabbott DJ, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor MD, Marra CA. How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma. Patient Preference and Adherence. 12: 2103-2110. PMID 30349204 DOI: 10.2147/Ppa.S168739  0.505
2018 Tsao NW, Sayre EC, Hanley G, Sadatsafavi M, Lynd LD, Marra CA, De Vera MA. Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study. Annals of the Rheumatic Diseases. PMID 29496718 DOI: 10.1136/Annrheumdis-2018-213023  0.489
2017 Patel AR, Lester RT, Marra CA, van der Kop ML, Ritvo P, Engel L, Karanja S, Lynd LD. The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya. Health and Quality of Life Outcomes. 15: 143. PMID 28716065 DOI: 10.1186/S12955-017-0708-7  0.527
2017 Mohammadi T, Bansback N, Marra F, Khakban A, Campbell JR, FitzGerald JM, Lynd LD, Marra CA. Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 20: 969-975. PMID 28712627 DOI: 10.1016/J.Jval.2017.04.007  0.5
2017 Marra CA, Harvard S, Grubisic M, Galo J, Clarke A, Elliott S, Lynd LD. Consumer preferences for food allergen labeling. Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology. 13: 19. PMID 28392808 DOI: 10.1186/S13223-017-0189-6  0.485
2017 Tsao NW, Khakban A, Gastonguay L, Zafari Z, Lynd LD, Marra CA. Opinions and preferences of British Columbia pharmacists and physicians on medication management services. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 150: 42-51. PMID 28286592 DOI: 10.1177/1715163516671746  0.524
2016 Khakban A, Mohammadi T, Lynd LD, Mabbott D, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor M, Marra CA. Societal preferences in the treatment of pediatric medulloblastoma: Balancing risk of death and quality of life. Pediatric Blood & Cancer. PMID 27917595 DOI: 10.1002/Pbc.26340  0.504
2016 Chen W, Lynd LD, FitzGerald JM, Marra CA, Balshaw R, To T, Tavakoli H, Sadatsafavi M. Excess medical costs in patients with asthma and the role of comorbidity. The European Respiratory Journal. PMID 27824603 DOI: 10.1183/13993003.01141-2016  0.569
2016 Raymakers AJ, McCormick N, Marra CA, Fitzgerald JM, Sin D, Lynd LD. Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review. Respirology (Carlton, Vic.). PMID 27761973 DOI: 10.1111/Resp.12919  0.507
2016 Davis E, Marra C, Gamble JM, Farrell J, Lockyer J, FitzGerald JM, Abu-Ashour W, Gillis C, Hawboldt J. Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial. Trials. 17: 502. PMID 27737686 DOI: 10.1186/S13063-016-1623-7  0.303
2016 Tavakoli H, FitzGerald JM, Chen W, Lynd L, Kendzerska T, Aaron S, Gershon A, Marra C, Sadatsafavi M. Ten-year trends in direct costs of asthma: a population-based study. Allergy. PMID 27455382 DOI: 10.1111/All.12993  0.548
2016 Lynd LD, Traboulsee A, Marra CA, Mittmann N, Evans C, Li KH, Carter M, Hategekimana C. Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study. Therapeutic Advances in Neurological Disorders. 9: 287-96. PMID 27366235 DOI: 10.1177/1756285616648060  0.524
2016 Zhang W, Guh D, Sun H, Marra CA, Lynd LD, Anis AH. The Impact of Price-Cap Regulations on Exit by Generic Pharmaceutical Firms. Medical Care. PMID 27213540 DOI: 10.1097/Mlr.0000000000000577  0.619
2016 Leung VW, Soon JA, Lynd LD, Marra CA, Levine M. Population-based evaluation of the effectiveness of two regimens for emergency contraception. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 26969148 DOI: 10.1016/J.Ijgo.2015.10.017  0.512
2016 Tsao NW, Lynd LD, Gastonguay L, Li K, Nakagawa B, Marra CA. Factors associated with pharmacists' perceptions of their working conditions and safety and effectiveness of patient care. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 149: 18-27. PMID 26798374 DOI: 10.1177/1715163515617777  0.536
2016 Zafari Z, Sadatsafavi M, Marra CA, Chen W, FitzGerald JM. Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma. Plos One. 11: e0146003. PMID 26751790 DOI: 10.1371/Journal.Pone.0146003  0.32
2016 Chen W, Marra CA, Lynd LD, FitzGerald JM, Zafari Z, Sadatsafavi M. The natural history of severe asthma and influences of early risk factors: a population-based cohort study. Thorax. 71: 267-75. PMID 26732738 DOI: 10.1136/Thoraxjnl-2015-207530  0.527
2016 Chen W, Lynd LD, FitzGerald JM, Marra CA, Balshaw R, To T, Tavakoli H, Sadatsafavi M. AB026. Excess medical cost in patients with asthma and the role of comorbidity Journal of Thoracic Disease. 8. DOI: 10.21037/Jtd.2016.S026  0.556
2015 Tsao NW, Khakban A, Gastonguay L, Li K, Lynd LD, Marra CA. Perceptions of British Columbia residents and their willingness to pay for medication management services provided by pharmacists. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 148: 263-73. PMID 26445584 DOI: 10.1177/1715163515597244  0.518
2015 O'Hara NN, Roy L, O'Hara LM, Spiegel JM, Lynd LD, FitzGerald JM, Yassi A, Nophale LE, Marra CA. Healthcare Worker Preferences for Active Tuberculosis Case Finding Programs in South Africa: A Best-Worst Scaling Choice Experiment. Plos One. 10: e0133304. PMID 26197344 DOI: 10.1371/Journal.Pone.0133304  0.497
2015 Law MR, Cheng L, Kratzer J, Morgan SG, Marra C, Lynd LD, Majumdar SR. Impact of allowing pharmacists to independently renew prescriptions: A population-based study. Journal of the American Pharmacists Association : Japha. 55: 398-404. PMID 26115380 DOI: 10.1331/Japha.2015.14262  0.516
2015 Khakban A, Sin DD, FitzGerald JM, Ng R, Zafari Z, McManus B, Hollander Z, Marra CA, Sadatsafavi M. 10-Year Trends in Direct Costs of COPD: A Population Based Study. Chest. PMID 26043120 DOI: 10.1378/Chest.15-0721  0.315
2015 Chen W, Lynd LD, FitzGerald JM, Marra CA, Rousseau R, Sadatsafavi M. The added effect of comorbidity on health-related quality of life in patients with asthma. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 24: 2507-17. PMID 26038225 DOI: 10.1007/S11136-015-0995-6  0.542
2015 Harrison M, Marra C, Shojania K, Bansback N. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment. Rheumatology (Oxford, England). 54: 1816-25. PMID 25989956 DOI: 10.1093/Rheumatology/Kev113  0.317
2015 Henrich N, Tsao N, Gastonguay L, Lynd L, Marra CA. BC Medication Management Project: Perspectives of pharmacists, patients and physicians. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 148: 90-100. PMID 25983759 DOI: 10.1177/1715163515569571  0.523
2015 Dragojlovic N, Rizzardo S, Bansback N, Mitton C, Marra CA, Lynd LD. Challenges in measuring the societal value of orphan drugs: insights from a canadian stated preference survey. The Patient. 8: 93-101. PMID 25586645 DOI: 10.1007/S40271-014-0109-5  0.571
2015 Trenaman L, Sadatsafavi M, Almeida F, Ayas N, Lynd L, Marra C, Stacey D, Bansback N. Exploring the Potential Cost-Effectiveness of Patient Decision Aids for Use in Adults with Obstructive Sleep Apnea: A Case Study. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 35: 671-82. PMID 25344130 DOI: 10.1177/0272989X14556676  0.536
2015 O’Hara N, Roy L, O’Hara L, Spiegel J, Lynd L, FitzGerald J, Yassi A, Nophale L, Marra C. TUBERCULOSIS screening preferences of Healthcare workers in South Africa: a best-worst scaling study to analyze variation by Occupation Value in Health. 18: A261. DOI: 10.1016/J.Jval.2015.03.1522  0.492
2015 Leung VWY, Soon JA, Lynd LD, Marra CA, Levine M. Population-based evaluation of the effectiveness of two regimens for emergency contraception International Journal of Gynecology and Obstetrics. DOI: 10.1016/j.ijgo.2015.10.017  0.445
2014 De Vera MA, Sadatsafavi M, Tsao NW, Lynd LD, Lester R, Gastonguay L, Galo J, FitzGerald JM, Brasher P, Marra CA. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial. Trials. 15: 488. PMID 25494702 DOI: 10.1186/1745-6215-15-488  0.548
2014 Tsao NW, Marra CA, Lynd LD, Thomas JM, Ferreira E. Community pharmacist surveillance of hypertension in pregnancy: Are we ready for prime time? Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 147: 307-15. PMID 25364340 DOI: 10.1177/1715163514543898  0.502
2014 Carruthers EC, Rogers P, Backman CL, Goldsmith CH, Gignac MA, Marra C, Village J, Li LC, Esdaile JM, Lacaille D. "Employment and arthritis: making it work" a randomized controlled trial evaluating an online program to help people with inflammatory arthritis maintain employment (study protocol). Bmc Medical Informatics and Decision Making. 14: 59. PMID 25043631 DOI: 10.1186/1472-6947-14-59  0.308
2014 Henrich N, Marra CA, Gastonguay L, Mabbott D, Malkin D, Fryer C, Bouffet E, Taylor MD, Hukin J, Scantlebury N, Lynd L. De-escalation of therapy for pediatric medulloblastoma: trade-offs between quality of life and survival. Pediatric Blood & Cancer. 61: 1300-4. PMID 24616367 DOI: 10.1002/Pbc.24990  0.509
2014 Marra F, Kaczorowski J, Gastonguay L, Marra CA, Lynd LD, Kendall P. Pharmacy-based Immunization in Rural Communities Strategy (PhICS): A community cluster-randomized trial. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 147: 33-44. PMID 24494014 DOI: 10.1177/1715163513514020  0.492
2014 Tsao NW, Shojania K, Marra CA. Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis. Expert Review of Pharmacoeconomics & Outcomes Research. 14: 9-18. PMID 24325566 DOI: 10.1586/14737167.2014.861742  0.319
2014 Sadatsafavi M, Lynd LD, Marra CA, FitzGerald JM. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study. Thorax. 69: 328-34. PMID 24281327 DOI: 10.1136/Thoraxjnl-2013-203998  0.522
2014 Raymakers AJ, Mayo J, Marra CA, FitzGerald M. Diagnostic strategies incorporating computed tomography angiography for pulmonary embolism: a systematic review of cost-effectiveness analyses. Journal of Thoracic Imaging. 29: 209-16. PMID 23846107 DOI: 10.1097/Rti.0B013E3182999E41  0.307
2014 Roy LM, Bansback N, Marra C, Carr R, Chilvers M, Lynd LD. Evaluating preferences for long term wheeze following RSV infection using TTO and best-worst scaling Allergy, Asthma & Clinical Immunology. 10. DOI: 10.1186/1710-1492-10-S1-A64  0.543
2014 Sadatsafavi M, Fitz Gerald M, Marra C, De Vera M, Zafari Z, Lynd L. Comparative Costs And Effectiveness Of Asthma Controller Therapies After Discharge From An Asthma-Related Hospitalization Value in Health. 17: A169. DOI: 10.1016/J.Jval.2014.03.988  0.536
2014 Rizzardo S, Bansback N, Mitton C, Marra C, Lynd L. How Canadians Value Rare Diseases Given Their Opportunity Cost? Value in Health. 17: A4. DOI: 10.1016/J.Jval.2014.03.027  0.531
2013 Davis EM, Lynd LD, Grubisic M, Kopec JA, Sayre EC, Cibere J, Esdaile J, Marra CA. Responsiveness of health state utility values in knee osteoarthritis. The Journal of Rheumatology. 40: 2075-82. PMID 24187098 DOI: 10.3899/Jrheum.130176  0.547
2013 Najafzadeh M, Johnston KM, Peacock SJ, Connors JM, Marra MA, Lynd LD, Marra CA. Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE). Bmc Health Services Research. 13: 454. PMID 24176050 DOI: 10.1186/1472-6963-13-454  0.52
2013 Sweeney K, Grubisic M, Marra CA, Kendall R, Li LC, Lynd LD. Comparison of HRQL between unicompartmental knee arthroplasty and total knee arthroplasty for the treatment of osteoarthritis. The Journal of Arthroplasty. 28: 187-90. PMID 23850408 DOI: 10.1016/J.Arth.2013.05.009  0.505
2013 Najafzadeh M, Marra CA, Lynd L, Wiseman S. Authors' response to "comparative effectiveness and personalized medicine" by Dr. J.C. Hornberger. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 16: 697. PMID 23796305 DOI: 10.1016/J.Jval.2013.02.005  0.491
2013 Sadatsafavi M, Lynd L, Marra C, Bedouch P, Fitzgerald M. Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study. The Journal of Allergy and Clinical Immunology. 132: 63-9. PMID 23545274 DOI: 10.1016/J.Jaci.2013.02.007  0.511
2013 Sadatsafavi M, FitzGerald M, Marra C, Lynd L. Costs and health outcomes associated with primary vs secondary care after an asthma-related hospitalization: a population-based study. Chest. 144: 428-35. PMID 23519289 DOI: 10.1378/Chest.12-2773  0.548
2013 Sadatsafavi M, Marra C, Marra F, Moran O, FitzGerald JM, Lynd L. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 16: 66-75. PMID 23337217 DOI: 10.1016/J.Jval.2012.09.006  0.499
2013 Almeida FR, Henrich N, Marra C, Lynd LD, Lowe AA, Tsuda H, Fleetham JA, Pliska B, Ayas N. Patient preferences and experiences of CPAP and oral appliances for the treatment of obstructive sleep apnea: a qualitative analysis. Sleep & Breathing = Schlaf & Atmung. 17: 659-66. PMID 22833346 DOI: 10.1007/S11325-012-0739-6  0.504
2013 Bedouch P, Sadatsafavi M, Marra CA, FitzGerald JM, Lynd LD. Correction: Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study Plos One. 8. DOI: 10.1371/annotation/a3275f00-6d75-4430-a0d6-5b4397ba501a  0.503
2013 Avina-Zubieta J, McCormick N, Sayre E, Sadatsafavi M, Esdaile J, Marra C. FRI0425 Longitudinal analysis of direct medical costs for systemic lupus erythematosus in british columbia, canada: A population-based study Annals of the Rheumatic Diseases. 71: 458.1-458. DOI: 10.1136/Annrheumdis-2012-Eular.2882  0.36
2013 Patel A, Lester R, Ritvo P, Marra C, Lynd L, Karanja S, Van Der Kop M. Discriminative Ability Of The Sf-12 In Kiswahili By Hiv Stage In Patients In Kenya Value in Health. 16: A95. DOI: 10.1016/J.Jval.2013.03.443  0.487
2013 Zafari Z, Thorlund K, FitzGerald M, Lynd L, Marra C, Sadatsafavi M. Impact of multiple treatment comparison meta-analysis on value of information evaluations: a case study of pharmacotherapies for chronic obstructive pulmonary diseases Value in Health. 16: A26-A27. DOI: 10.1016/J.Jval.2013.03.156  0.512
2013 Zafari Z, Sadatsafavi M, FitzGerald M, Lynd L, Marra C. The Humanistic And Economic Impact Of Following Evidence-Based Asthma Controller Therapy: A Simulation Study Value in Health. 16: A235. DOI: 10.1016/J.Jval.2013.03.1195  0.526
2012 Marra CA, Lynd LD, Grindrod KA, Joshi P, Isakovic A. Evaluating the labour costs associated with pharmacy adaptation services in British Columbia. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 145: 78-82. PMID 23509507 DOI: 10.3821/145.2.Cpj78  0.539
2012 Najafzadeh M, Marra CA, Lynd LD, Wiseman SM. Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer Value in Health. 15: 1005-1012. PMID 23244801 DOI: 10.1016/J.Jval.2012.06.017  0.544
2012 Bedouch P, Sadatsafavi M, Marra CA, FitzGerald JM, Lynd LD. Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. Plos One. 7: e50949. PMID 23227222 DOI: 10.1371/Journal.Pone.0050949  0.565
2012 Najafzadeh M, Marra CA, Lynd LD, Sadatsafavi M, FitzGerald JM, McManus B, Sin D. Future impact of various interventions on the burden of COPD in Canada: a dynamic population model. Plos One. 7: e46746. PMID 23071626 DOI: 10.1371/Journal.Pone.0046746  0.512
2012 Marra CA, Lynd LD, Colley L, Harvard SS, Lacaille D, Schwenger E, Anis AH, Esdaile JM. Risk of gastrointestinal events in patients with rheumatoid arthritis after withdrawal of rofecoxib. The Journal of Rheumatology. 39: 910-5. PMID 22422500 DOI: 10.3899/Jrheum.110604  0.632
2012 Najafzadeh M, Lynd LD, Davis JC, Bryan S, Anis A, Marra M, Marra CA. Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 520-6. PMID 22241089 DOI: 10.1038/Gim.2011.26  0.629
2012 Raymakers AJ, Sadatsafavi M, Marra F, Marra CA. Economic and humanistic burden of external genital warts. Pharmacoeconomics. 30: 1-16. PMID 22201520 DOI: 10.2165/11591170-000000000-00000  0.325
2011 Anis A, Harvard S, Marra C. Ontario's plunging price-caps on generics: deeper dives may drown some drugs. Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal. 5: e149-52. PMID 22046229  0.456
2011 Wilby K, Marra CA, da Silva JH, Grubisic M, Harvard S, Lynd LD. Randomized controlled trial evaluating pictogram augmentation of HIV medication information. The Annals of Pharmacotherapy. 45: 1378-83. PMID 22028420 DOI: 10.1345/Aph.1Q091  0.524
2011 Guo N, Marra CA, FitzGerald JM, Elwood RK, Anis AH, Marra F. Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 937-43. PMID 21914516 DOI: 10.1016/J.Jval.2011.05.003  0.504
2011 Woolcott JC, Khan KM, Mitrovic S, Anis AH, Marra CA. The cost of fall related presentations to the ED: a prospective, in-person, patient-tracking analysis of health resource utilization. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 23: 1513-9. PMID 21892675 DOI: 10.1007/S00198-011-1764-1  0.541
2011 Harrison MJ, Bansback NJ, Marra CA, Drummond M, Tugwell PS, Boonen A. Valuing health for clinical and economic decisions: directions relevant for rheumatologists. The Journal of Rheumatology. 38: 1770-5. PMID 21807800 DOI: 10.3899/Jrheum.110404  0.321
2011 Marra F, Marra CA, Richardson K, Lynd LD, Fitzgerald MJ. Antibiotic consumption in children prior to diagnosis of asthma. Bmc Pulmonary Medicine. 11: 32. PMID 21627795 DOI: 10.1186/1471-2466-11-32  0.509
2011 Marra CA, Lynd LD, Harvard SS, Grubisic M. Agreement between aggregate and individual-level measures of income and education: a comparison across three patient groups. Bmc Health Services Research. 11: 69. PMID 21453534 DOI: 10.1186/1472-6963-11-69  0.516
2011 Marra CA, Bansback N, Anis AH, Shojania K. Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis. Clinical Rheumatology. 30: S9-18. PMID 21359506 DOI: 10.1007/S10067-010-1635-8  0.572
2011 Oteng B, Marra F, Lynd LD, Ogilvie G, Patrick D, Marra CA. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. Sexually Transmitted Infections. 87: 52-7. PMID 20956352 DOI: 10.1136/Sti.2009.041392  0.48
2011 Davis JC, Marra CA, Robertson MC, Khan KM, Najafzadeh M, Ashe MC, Liu-Ambrose T. Economic evaluation of dose-response resistance training in older women: A cost-effectiveness and cost-utility analysis Osteoporosis International. 22: 1355-1366. PMID 20683707 DOI: 10.1007/S00198-010-1356-5  0.301
2011 Grindrod KA, Lynd LD, Joshi P, Rosenthal M, Isakovic A, Marra CA. Pharmacy owner and manager perceptions of pharmacy adaptation services in British Columbia Canadian Pharmacists Journal. 144: 231-235. DOI: 10.3821/1913-701X-144.5.231  0.548
2011 Henrich N, Joshi P, Grindrod K, Lynd L, Marra C. Family Physicians' Perceptions of Pharmacy Adaptation Services in British Columbia Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada. 144: 172-178. DOI: 10.3821/1913-701X-144.4.172  0.532
2011 Leung V, Soon J, Lynd L, Marra C, Levine M. Comparison of pregnancy rates after two hormonal emergency contraceptives Contraception. 84: 333-334. DOI: 10.1016/j.contraception.2011.05.118  0.408
2010 Bahadori K, Quon BS, Doyle-Waters MM, Marra C, Fitzgerald JM. A systematic review of economic evaluations of therapy in asthma. Journal of Asthma and Allergy. 3: 33-42. PMID 21437038 DOI: 10.2147/Jaa.S11038  0.312
2010 Guimarães C, Marra CA, Gill S, Simpson S, Meneilly G, Queiroz RH, Lynd LD. A discrete choice experiment evaluation of patients' preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management. Patient Preference and Adherence. 4: 433-40. PMID 21301591 DOI: 10.2147/Ppa.S14217  0.518
2010 Law MR, Morgan SG, Majumdar SR, Lynd LD, Marra CA. Effects of prescription adaptation by pharmacists. Bmc Health Services Research. 10: 313. PMID 21083922 DOI: 10.1186/1472-6963-10-313  0.553
2010 Grindrod KA, Marra CA, Colley L, Tsuyuki RT, Lynd LD. Pharmacists' preferences for providing patient-centered services: a discrete choice experiment to guide health policy. The Annals of Pharmacotherapy. 44: 1554-64. PMID 20841513 DOI: 10.1345/Aph.1P228  0.522
2010 Guimarães C, Marra CA, Gill S, Meneilly G, Simpson S, Godoy AL, Foss de MC, Freitas, Queiroz RH, Lynd L. Exploring patients' perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study. Patient Preference and Adherence. 4: 171-9. PMID 20694179 DOI: 10.2147/Ppa.S10178  0.509
2010 Lynd LD, Marra CA, Najafzadeh M, Sadatsafavi M. A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework. Pharmacoepidemiology and Drug Safety. 19: 1172-80. PMID 20602338 DOI: 10.1002/Pds.1994  0.532
2010 Guo N, Marra F, Fitzgerald JM, Elwood RK, Marra CA. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis. The European Respiratory Journal. 36: 206-8. PMID 20595167 DOI: 10.1183/09031936.00159409  0.328
2010 Sadatsafavi M, Marra C, Li D, Illes J. An ounce of prevention is worth a pound of cure: a cost-effectiveness analysis of incidentally detected aneurysms in functional MRI research. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 13: 761-9. PMID 20561317 DOI: 10.1111/J.1524-4733.2010.00755.X  0.312
2010 Sadatsafavi M, Lynd L, Marra C, Carleton B, Tan WC, Sullivan S, Fitzgerald JM. Direct health care costs associated with asthma in British Columbia. Canadian Respiratory Journal. 17: 74-80. PMID 20422063 DOI: 10.1155/2010/361071  0.563
2010 Woolcott JC, Ashe MC, Miller WC, Shi P, Marra CA. Does physical activity reduce seniors' need for healthcare?: A study of 24 281 Canadians British Journal of Sports Medicine. 44: 902-904. PMID 19854760 DOI: 10.1136/Bjsm.2008.057216  0.311
2009 Finckh A, Bansback N, Marra CA, Anis AH, Michaud K, Lubin S, White M, Sizto S, Liang MH. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Annals of Internal Medicine. 151: 612-21. PMID 19884622 DOI: 10.7326/0003-4819-151-9-200911030-00006  0.53
2009 Guimarães C, Marra CA, Colley L, Gill S, Simpson S, Meneilly G, Queiroz RH, Lynd LD. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes. Diabetes Technology & Therapeutics. 11: 567-73. PMID 19764835 DOI: 10.1089/Dia.2009.0034  0.506
2009 Guimarães C, Marra CA, Colley L, Gill S, Simpson SH, Meneilly GS, Queiroz RH, Lynd LD. A valuation of patients' willingness-to-pay for insulin delivery in diabetes. International Journal of Technology Assessment in Health Care. 25: 359-66. PMID 19619355 DOI: 10.1017/S0266462309990055  0.507
2009 Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM. Economic burden of asthma: a systematic review. Bmc Pulmonary Medicine. 9: 24. PMID 19454036 DOI: 10.1186/1471-2466-9-24  0.567
2009 Marra F, Marra CA, Richardson K, Lynd LD, Kozyrskyj A, Patrick DM, Bowie WR, Fitzgerald JM. Antibiotic use in children is associated with increased risk of asthma. Pediatrics. 123: 1003-10. PMID 19255032 DOI: 10.1542/Peds.2008-1146  0.518
2009 Bansback N, Marra CA. Now that we know what's BeSt, what is good value for the money? Arthritis and Rheumatism. 61: 289-90. PMID 19248126 DOI: 10.1002/Art.24355  0.389
2009 Bansback N, Marra CA, Finckh A, Anis A. The economics of treatment in early rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology. 23: 83-92. PMID 19233048 DOI: 10.1016/J.Berh.2008.11.005  0.573
2009 Rosenthal M, Grindrod KA, Lynd L, Marra CA, Bougher D, Wilgosh C, Tsuyuki RT. Pharmacists' Perspectives on Providing Chronic Disease Management Services in the Community — Part II: Development and Implementation of Services Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada. 142: 284-288.e1. DOI: 10.3821/1913-701X-142.6.284  0.471
2009 Grindrod KA, Rosenthal M, Lynd L, Marra CA, Bougher D, Wilgosh C, Tsuyuki RT. Pharmacists' Perspectives on Providing Chronic Disease Management Services in the Community — Part I: Current Practice Environment Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada. 142: 234-239. DOI: 10.3821/1913-701X-142.5.234  0.478
2009 Oteng B, Marra C, Lynd L, Marra F. PIN46 EVALUATING SOCIETAL PREFERENCES FOR THE HUMAN PAPILLOMAVIRUS VACCINES USING DISCRETE CHOICE EXPERIMENT Value in Health. 12: A118. DOI: 10.1016/S1098-3015(10)73653-6  0.488
2008 Zhang W, Bansback N, Guh D, Li X, Nosyk B, Marra CA, Anis AH. Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis. The Journal of Rheumatology. 35: 1729-36. PMID 18688916  0.454
2008 Bansback NJ, Anis AH, Marra CA. Patient reported outcomes for rheumatoid arthritis: where are we and where are we going? The Journal of Rheumatology. 35: 1482-3. PMID 18671320  0.447
2008 Najafzadeh M, Marra CA, Sadatsafavi M, Aaron SD, Sullivan SD, Vandemheen KL, Jones PW, Fitzgerald JM. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD Thorax. 63: 962-967. PMID 18621985 DOI: 10.1136/Thx.2007.089557  0.341
2008 Bansback N, Harrison M, Brazier J, Davies L, Kopec J, Marra C, Symmons D, Anis A. Health state utility values: a description of their development and application for rheumatic diseases. Arthritis and Rheumatism. 59: 1018-26. PMID 18576311 DOI: 10.1002/Art.23813  0.574
2008 Sadatsafavi M, Najafzadeh M, Lynd L, Marra C. Reliability studies of diagnostic tests are not using enough observers for robust estimation of interobserver agreement: a simulation study. Journal of Clinical Epidemiology. 61: 722-7. PMID 18486446 DOI: 10.1016/J.Jclinepi.2007.10.023  0.499
2008 McTaggart-Cowan HM, Marra CA, Yang Y, Brazier JE, Kopec JA, FitzGerald JM, Anis AH, Lynd LD. The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 17: 453-62. PMID 18274882 DOI: 10.1007/S11136-008-9309-6  0.651
2008 Sadatsafavi M, Najafzadeh M, Marra C. Technical note: acceptability curves could be misleading when correlated strategies are compared. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 28: 306-7. PMID 18270304 DOI: 10.1177/0272989X07312726  0.316
2007 Regier DA, Marra CA, Lynd L. Economic evaluations of anticoagulants for the prophylaxis of venous thromboembolism following major trauma. Expert Review of Pharmacoeconomics & Outcomes Research. 7: 403-13. PMID 20528423 DOI: 10.1586/14737167.7.4.403  0.546
2007 Reynolds J, Shojania K, Marra CA. Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis. Pharmacotherapy. 27: 1693-701. PMID 18041889 DOI: 10.1592/Phco.27.12.1693  0.302
2007 Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond T, Brazier J. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis and Rheumatism. 57: 963-71. PMID 17665482 DOI: 10.1002/Art.22885  0.536
2007 Bansback N, Maetzel A, Drummond M, Anis A, Marra C, Conway P, Boers M, Tugwell P, Boonen A. Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis. The Journal of Rheumatology. 34: 1178-83. PMID 17477483  0.492
2006 Marra CA, Marion SA, Guh DP, Najafzadeh M, Wolfe F, Esdaile JM, Clarke AE, Gignac MA, Anis AH. Not all "quality-adjusted life years" are equal. Journal of Clinical Epidemiology. 60: 616-24. PMID 17493521 DOI: 10.1016/J.Jclinepi.2006.09.006  0.51
2006 Tan MC, Regier DA, Esdaile JM, Lynd LD, Anis AH, Marra CA. Health economic evaluation: a primer for the practicing rheumatologist. Arthritis and Rheumatism. 55: 648-56. PMID 16874788 DOI: 10.1002/Art.22105  0.64
2006 Regier DA, Sunderji R, Lynd LD, Gin K, Marra CA. Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 174: 1847-52. PMID 16785459 DOI: 10.1503/Cmaj.051104  0.549
2006 Rashidi AA, Anis AH, Marra CA. Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients. Health and Quality of Life Outcomes. 4: 25. PMID 16626489 DOI: 10.1186/1477-7525-4-25  0.542
2006 Marra F, Lynd L, Coombes M, Richardson K, Legal M, Fitzgerald JM, Marra CA. Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis. Chest. 129: 610-8. PMID 16537858 DOI: 10.1378/Chest.129.3.610  0.516
2006 Marra CA, Lynd LD, Anis AH, Esdaile JM. Approval process and access to prescription drugs in Canada. Arthritis and Rheumatism. 55: 9-11. PMID 16463404 DOI: 10.1002/Art.21709  0.615
2005 Anis AH, Guh DP, Lacaille D, Marra CA, Rashidi AA, Li X, Esdaile JM. When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 173: 1335-40. PMID 16301701 DOI: 10.1503/Cmaj.045146  0.569
2005 Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, Brazier JE, Fortin PR, Anis AH. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 14: 1333-44. PMID 16047508 DOI: 10.1007/S11136-004-6012-0  0.53
2005 De Civita M, Regier D, Alamgir AH, Anis AH, Fitzgerald MJ, Marra CA. Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics. 23: 659-85. PMID 15987225 DOI: 10.2165/00019053-200523070-00003  0.53
2005 Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH, Marra CA. An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists. Drugs. 65: 473-96. PMID 15733011 DOI: 10.2165/00003495-200565040-00004  0.579
2005 Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science & Medicine (1982). 60: 1571-82. PMID 15652688 DOI: 10.1016/J.Socscimed.2004.08.034  0.539
2004 Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, Chalmers A, Anis AH. A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Medical Care. 42: 1125-31. PMID 15586840 DOI: 10.1097/00005650-200411000-00012  0.538
2004 Marra CA, Lynd LD, Esdaile JM, Kopec J, Anis AH. The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment. Rheumatology (Oxford, England). 43: 1390-7. PMID 15292531 DOI: 10.1093/Rheumatology/Keh334  0.649
2003 Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH. Infliximab treatment of rheumatoid arthritis and Crohn's disease. The Annals of Pharmacotherapy. 37: 1256-65. PMID 12921510 DOI: 10.1345/Aph.1C039  0.502
2002 Marra CA, Esdaile JM, Anis AH. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. The Journal of Rheumatology. 29: 2507-12. PMID 12465143  0.474
2001 Marra CA, Esdaile JM, Guh D, Fisher JH, Chalmers A, Anis AH. The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry. Arthritis and Rheumatism. 45: 240-5. PMID 11409664 DOI: 10.1002/1529-0131(200106)45:3<240::Aid-Art255>3.0.Co;2-I  0.503
2001 Wai AO, Frighetto L, Marra CA, Chan E, Jewesson PJ. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective. Pharmacoeconomics. 18: 451-7. PMID 11151398 DOI: 10.2165/00019053-200018050-00004  0.317
2000 Marra C, Guh D, Fisher J, Chalmers A, Esdaile J, Anis A. PAR7: THE LONGTERM SAFETY AND EFFECTIVENESS OF CYCLOSPORINE IN PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS (RA) Value in Health. 3: 98. DOI: 10.1016/S1098-3015(11)70444-2  0.506
1998 Zed PJ, Frighetto L, Sunderji R, Marra CA. Cost-effectiveness analysis of abciximab: a Canadian hospital perspective. The Annals of Pharmacotherapy. 32: 536-42. PMID 9606473 DOI: 10.1345/Aph.17336  0.301
1996 Marra CA, Lynd LD, McKerrow R, Carleton BC. Drug and poison information resources on the Internet, Part 1: An introduction. Pharmacotherapy. 16: 537-546. DOI: 10.1002/J.1875-9114.1996.Tb03636.X  0.534
1996 Marra CA, Levine M, McKerrow R, Carleton BC. Overview of Health‐Related Quality‐of‐Life Measures for Pediatric Patients: Application in the Assessment of Pharmacotherapeutic and Pharmacoeconomic Outcomes Pharmacotherapy. 16: 879-888. DOI: 10.1002/J.1875-9114.1996.Tb03005.X  0.314
1996 Marra CA, Carleton BC, Lynd LD, Marra F, McDougal AR, Chow D, McKerrow R. Drug and Poison Information Resources on the Internet, Part 2: Identification and Evaluation Pharmacotherapy. 16: 806-818. DOI: 10.1002/J.1875-9114.1996.Tb02998.X  0.515
Low-probability matches (unlikely to be authored by this person)
2015 Davis JC, Bryan S, Marra CA, Hsiung GY, Liu-Ambrose T. Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia. British Journal of Sports Medicine. 49: 1343-7. PMID 24195918 DOI: 10.1136/Bjsports-2013-092743  0.299
2018 McCormick N, Marra CA, Sadatsafavi M, Aviña-Zubieta JA. Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study. Lupus. 27: 1247-1258. PMID 29665755 DOI: 10.1177/0961203318768882  0.298
2010 Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 376: 1838-45. PMID 21071074 DOI: 10.1016/S0140-6736(10)61997-6  0.296
2017 McCormick N, Reimer K, Famouri A, Marra CA, Aviña-Zubieta JA. Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) from British Columbia, Canada. Bmj Open. 7: e013977. PMID 28637725 DOI: 10.1136/Bmjopen-2016-013977  0.296
2000 Stiver G, Wai A, Chase L, Frighetto L, Marra C, Jewessen P. Outpatient Intravenous Antibiotic Therapy: The Vancouver Hospital experience Canadian Journal of Infectious Diseases. 11: 11A-14A. DOI: 10.1155/2000/912402  0.295
1998 Marra CA, Patrick DM, Reynolds R, Marra F. Chlamydia trachomatis in adolescents and adults. Clinical and economic implications Pharmacoeconomics. 13: 191-222. PMID 10178647 DOI: 10.2165/00019053-199813020-00004  0.293
2009 Guo N, Marra F, FitzGerald J, Elwood R, Marra C. PIN43 THE IMPACT OF ADVERSE DRUG REACTIONS ASSOCIATED WITH ANTI-TUBERCULOSIS MEDICATIONS ON HEALTH-RELATED QUALITY OF LIFE: A LONGITUDINAL ANALYSIS Value in Health. 12: A117-A118. DOI: 10.1016/S1098-3015(10)73650-0  0.293
2009 Marra F, Ogilvie G, Colley L, Kliewer E, Marra CA. Epidemiology and costs associated with genital warts in Canada. Sexually Transmitted Infections. 85: 111-5. PMID 18981170 DOI: 10.1136/Sti.2008.030999  0.293
2010 Regier DA, Friedman JM, Marra CA. Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. American Journal of Human Genetics. 86: 765-72. PMID 20398885 DOI: 10.1016/J.Ajhg.2010.03.009  0.292
2009 Najafzadeh M, Marra CA, Galanis E, Patrick DM. Cost effectiveness of Herpes Zoster Vaccine in Canada Pharmacoeconomics. 27: 991-1004. PMID 19908924 DOI: 10.2165/11314010-000000000-00000  0.292
2007 Regier DA, Bansback N, Dar Santos A, Marra CA. Cost-effectiveness of tumor necrosis factor-alpha antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Expert Review of Pharmacoeconomics & Outcomes Research. 7: 155-69. PMID 20528442 DOI: 10.1586/14737167.7.2.155  0.292
2012 Tsao NW, Bansback NJ, Shojania K, Marra CA. The issue of comparators in economic evaluations of biologic response modifiers in rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology. 26: 659-76. PMID 23218430 DOI: 10.1016/J.Berh.2012.07.012  0.29
2015 Khan KM, Windt A, Davis JC, Dawes M, Liu-Ambrose T, Madden K, Marra CA, Housden L, Hoppmann C, Adams DJ. Group Medical Visits (GMVs) in primary care: an RCT of group-based versus individual appointments to reduce HbA1c in older people. Bmj Open. 5: e007441. PMID 26169803 DOI: 10.1136/Bmjopen-2014-007441  0.29
2010 Slobogean GP, Younger A, Apostle KL, Marra CA, Wing K, Penner M, Daniels T, Glazebrook M. Preference-based quality of life of end-stage ankle arthritis treated with arthroplasty or arthrodesis. Foot & Ankle International. 31: 563-6. PMID 20663421 DOI: 10.3113/Fai.2010.0563  0.289
2017 Marra C, Johnston K, Santschi V, Tsuyuki RT. Cost-effectiveness of pharmacist care for managing hypertension in Canada. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 150: 184-197. PMID 28507654 DOI: 10.1177/1715163517701109  0.289
2010 Grindrod KA, Marra CA, Colley L, Cibere J, Tsuyuki RT, Esdaile JM, Gastonguay L, Kopec J. After patients are diagnosed with knee osteoarthritis, what do they do? Arthritis Care & Research. 62: 510-5. PMID 20391506 DOI: 10.1002/Acr.20170  0.289
2014 Marra CA, Grubisic M, Cibere J, Grindrod KA, Woolcott JC, Gastonguay L, Esdaile JM. Cost-utility analysis of a multidisciplinary strategy to manage osteoarthritis of the knee: economic evaluation of a cluster randomized controlled trial study. Arthritis Care & Research. 66: 810-6. PMID 24249680 DOI: 10.1002/Acr.22232  0.288
2016 Harrison M, Marra CA, Bansback N. Preferences for 'New' Treatments Diminish in the Face of Ambiguity. Health Economics. PMID 27174417 DOI: 10.1002/Hec.3353  0.286
2018 Rai SK, Howren A, Wilcox ES, Townsend AF, Marra CA, Aviña-Zubieta JA, De Vera MA. Exploring strategies to support medication adherence in patients with inflammatory arthritis: a patient-oriented qualitative study using an interactive focus group activity. Patient Preference and Adherence. 12: 2015-2025. PMID 30323571 DOI: 10.2147/Ppa.S174672  0.285
2014 Sadatsafavi M, Marra C, Aaron S, Bryan S. Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods. Trials. 15: 201. PMID 24888356 DOI: 10.1186/1745-6215-15-201  0.285
2008 Guo N, Marra CA, Marra F, Moadebi S, Elwood RK, Fitzgerald JM. Health state utilities in latent and active tuberculosis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 11: 1154-61. PMID 18489493 DOI: 10.1111/J.1524-4733.2008.00355.X  0.284
2020 Nair D, Green JA, Marra CA. Pharmacists of the future: What determines graduates' desire to engage in patient-centred services? Research in Social & Administrative Pharmacy : Rsap. PMID 32482588 DOI: 10.1016/J.Sapharm.2020.04.030  0.282
2019 Stamp LK, Chan SJ, Marra C, Helme C, Treharne GJ. Tapering biologic therapy for people with rheumatoid arthritis in remission: A review of patient perspectives and associated clinical evidence. Musculoskeletal Care. PMID 31148375 DOI: 10.1002/Msc.1404  0.282
2006 Marra C. Rheumatoid arthritis: a primer for pharmacists. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 63: S4-10. PMID 16960246 DOI: 10.2146/Ajhp060362  0.281
2017 Patel AR, Kessler J, Braithwaite RS, Nucifora KA, Thirumurthy H, Zhou Q, Lester RT, Marra CA. Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya. Medicine. 96: e6078. PMID 28207516 DOI: 10.1097/Md.0000000000006078  0.281
2008 AlGhanim N, Comondore VR, Fleetham J, Marra CA, Ayas NT. The economic impact of obstructive sleep apnea. Lung. 186: 7-12. PMID 18066623 DOI: 10.1007/S00408-007-9055-5  0.279
2016 Alwashmi M, Hawboldt J, Davis E, Marra C, Gamble JM, Abu Ashour W. The Effect of Smartphone Interventions on Patients With Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review and Meta-Analysis. Jmir Mhealth and Uhealth. 4: e105. PMID 27589898 DOI: 10.2196/Mhealth.5921  0.277
2009 Guo N, Marra F, Marra CA. Measuring health-related quality of life in tuberculosis: a systematic review. Health and Quality of Life Outcomes. 7: 14. PMID 19224645 DOI: 10.1186/1477-7525-7-14  0.277
2012 Marra F, Marra CA, Patrick DM. Cost effectiveness analysis of azithromycin and doxycycline for Chlamydia trachomatis infection in women: A Canadian perspective. The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses. 8: 202-8. PMID 22346517 DOI: 10.1155/1997/870203  0.275
2010 Davis JC, Robertson MC, Ashe MC, Liu-Ambrose T, Khan KM, Marra CA. International comparison of cost of falls in older adults living in the community: A systematic review Osteoporosis International. 21: 1295-1306. PMID 20195846 DOI: 10.1007/S00198-009-1162-0  0.275
2016 Bansback N, Harrison M, Marra C. Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments? Medical Decision Making : An International Journal of the Society For Medical Decision Making. 36: 490-502. PMID 26304064 DOI: 10.1177/0272989X15600708  0.275
2008 Marra CA, Tsuyuki RT, Soon JA, Gastonguay L, Oteng B, Cibere J, McAuley C, Esdaile JM, McGregor M, Khan K. Design of a randomized trial of a multidisciplinary intervention for knee osteoarthritis: Pharmacist Initiated Intervention Trial in Osteoarthritis (PhIT-OA) Canadian Pharmacists Journal. 141: 33-38. DOI: 10.3821/1913-701X(2008)141[33:Doarto]2.0.Co;2  0.275
1999 Frighetto L, Loewen PS, Dolman J, Marra CA. Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery. Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie. 46: 536-43. PMID 10391600 DOI: 10.1007/Bf03013543  0.274
2014 van Karnebeek CD, Mohammadi T, Tsao N, Sinclair G, Sirrs S, Stockler S, Marra C. Health economic evaluation of plasma oxysterol screening in the diagnosis of Niemann-Pick Type C disease among intellectually disabled using discrete event simulation. Molecular Genetics and Metabolism. 114: 226-32. PMID 25095726 DOI: 10.1016/J.Ymgme.2014.07.004  0.274
2005 Marra CA, Frighetto L, Goodfellow AF, Wai AO, Chase ML, Nicol RE, Leong CA, Tomlinson S, Ferreira BM, Jewesson PJ. Willingness to pay to assess patient preferences for therapy in a Canadian setting. Bmc Health Services Research. 5: 43. PMID 15941474 DOI: 10.1186/1472-6963-5-43  0.273
2013 Najafzadeh M, Davis JC, Joshi P, Marra C. Barriers for integrating personalized medicine into clinical practice: a qualitative analysis. American Journal of Medical Genetics. Part A. 161: 758-63. PMID 23444119 DOI: 10.1002/Ajmg.A.35811  0.273
2000 Balen RM, Marra CA, Zed PJ, Cohen M, Frighetto L. Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes. A Canadian hospital perspective. Pharmacoeconomics. 16: 533-42. PMID 10662478 DOI: 10.2165/00019053-199916050-00009  0.271
2002 St Pierre E, Frighetto L, Marra CA. Influence of standardized orders on postoperative nausea and vomiting after gynecologic surgery. The Annals of Pharmacotherapy. 36: 210-7. PMID 11847936 DOI: 10.1345/Aph.1A137  0.271
1999 Loewen PS, Marra CA, Marra F. Systematic review of the treatment of early Lyme disease. Drugs. 57: 157-73. PMID 10188758 DOI: 10.2165/00003495-199957020-00003  0.27
2009 Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Archives of Internal Medicine. 169: 1952-60. PMID 19933955 DOI: 10.1001/Archinternmed.2009.357  0.269
2009 Regier DA, Friedman JM, Makela N, Ryan M, Marra CA. Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children. Clinical Genetics. 75: 514-21. PMID 19508416 DOI: 10.1111/J.1399-0004.2009.01193.X  0.269
2005 Marra C, Maetzel A, Farewell V, Rashidi A, Shi P, Antoni C, Wong J, Gladman D. MS4 THE COST-EFFECTIVENESS OF ADDING INFLIXIMAB TO USUAL THERAPY IN THE TREATMENT OF PSORIATIC ARTHRITIS Value in Health. 8: 242. DOI: 10.1016/S1098-3015(10)62585-5  0.269
2013 van der Kop ML, Ojakaa DI, Patel A, Thabane L, Kinagwi K, Ekström AM, Smillie K, Karanja S, Awiti P, Mills E, Marra C, Kyomuhangi LB, Lester RT. The effect of weekly short message service communication on patient retention in care in the first year after HIV diagnosis: study protocol for a randomised controlled trial (WelTel Retain). Bmj Open. 3. PMID 23794578 DOI: 10.1136/Bmjopen-2013-003155  0.269
2008 Marra CA, Marra F, Colley L, Moadebi S, Elwood RK, Fitzgerald JM. Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection. Chest. 133: 396-403. PMID 18198260 DOI: 10.1378/Chest.07-1494  0.268
2006 Marra C, Marra F, Richardson K, Fitzgerald M. In Reply: Antibiotic Use During the First Year of Life and Asthma Chest. 130: 1624-1625. DOI: 10.1016/S0012-3692(15)37348-7  0.266
2019 Suz Jack C, Stamp L, Marra C, Liebergreen N, Ndukwe H, Treharne G. PMS74 TAPERING BIOLOGIC? AN INSIGHT AND PERSPECTIVE OF RHEUMATOID ARTHRITIS PATIENTS Value in Health. 22: S707. DOI: 10.1016/J.Jval.2019.09.1615  0.265
2000 Marra CA, Patrick DM, Marra F. A Cost-effectiveness Analysis of Pneumococcal Vaccination in Street-involved, HIV-infected Patients Canadian Journal of Public Health. 91: 334-339. DOI: 10.17269/Cjph.91.156  0.264
2019 Donnan JR, Johnston K, Chibrikov E, Marra CA, Aubrey-Bassler K, Najafzadeh M, Nguyen H, Gamble JM. Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment. Canadian Journal of Diabetes. PMID 31311729 DOI: 10.1016/J.Jcjd.2019.04.014  0.263
2012 Davis JC, Liu-Ambrose T, Khan KM, Robertson MC, Marra CA. SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 23: 1849-57. PMID 21909728 DOI: 10.1007/S00198-011-1770-3  0.263
2002 Goodfellow AF, Wai AO, Frighetto L, Marra CA, Ferreira BM, Chase ML, Nicol RE, Leong CA, Tomlinson S, Jewesson PJ. Quality-of-life assessment in an outpatient parenteral antibiotic program. The Annals of Pharmacotherapy. 36: 1851-5. PMID 12452743 DOI: 10.1345/Aph.1C153  0.263
2015 Davis JC, Dian L, Khan KM, Bryan S, Marra CA, Hsu CL, Jacova P, Chiu BK, Liu-Ambrose T. Cognitive status is a determinant of health resource utilization among individuals with a history of falls: a 12-month prospective cohort study. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 26449355 DOI: 10.1007/S00198-015-3350-4  0.263
1999 Marra FO, Frighetto LO, Marra CA, Sleigh KM, Stiver HG, Bryce EA, Reynolds RP, Jewesson PJ. Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective. The Annals of Pharmacotherapy. 33: 156-62. PMID 10084409 DOI: 10.1345/Aph.17366  0.262
2015 Liu-Ambrose T, Davis JC, Hsu CL, Gomez C, Vertes K, Marra C, Brasher PM, Dao E, Khan KM, Cook W, Donaldson MG, Rhodes R, Dian L. Action seniors! - secondary falls prevention in community-dwelling senior fallers: study protocol for a randomized controlled trial. Trials. 16: 144. PMID 25873254 DOI: 10.1186/S13063-015-0648-7  0.262
2006 Brown JR, Marra C, Pucino F, Resman-Targoff BH. Improving rheumatoid arthritis outcomes: how do we get there? American Journal of Health-System Pharmacy. 63. PMID 16960247 DOI: 10.2146/Ajhp060366  0.262
2008 Tan MC, Marra CA, Sadatsafavi M, Marra F, Morán-Mendoza O, Moadebi S, Elwood RK, FitzGerald JM. Cost-effectiveness of LTBI treatment for TB contacts in British Columbia. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 11: 842-52. PMID 18489519 DOI: 10.1111/J.1524-4733.2008.00334.X  0.262
1995 Marra CA, Carleton BC, Basmadjian D, Levine M, McKerrow R, Bates RD. Comment: Cost of rhDNase in cystic fibrosis Annals of Pharmacotherapy. 29: 1050-1051. PMID 8845550 DOI: 10.1177/106002809502901024  0.261
2011 Davis JC, Marra CA, Liu-Ambrose TY. Falls-related self-efficacy is independently associated with quality-adjusted life years in older women. Age and Ageing. 40: 340-6. PMID 21436152 DOI: 10.1093/Ageing/Afr019  0.26
2010 Davis JC, Marra CA, Najafzadeh M, Liu-Ambrose T. The independent contribution of executive functions to health related quality of life in older women. Bmc Geriatrics. 10: 16. PMID 20359355 DOI: 10.1186/1471-2318-10-16  0.26
2004 Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald JM. Factors influencing quality of life in patients with active tuberculosis. Health and Quality of Life Outcomes. 2: 58. PMID 15496227 DOI: 10.1186/1477-7525-2-58  0.259
2009 Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G. Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review. Pharmacoeconomics. 27: 127-47. PMID 19254046 DOI: 10.2165/00019053-200927020-00004  0.258
2008 Tan MC, Ayas NT, Mulgrew A, Cortes L, FitzGerald JM, Fleetham JA, Schulzer M, Ryan CF, Ghaeli R, Cooper P, Marra CA. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia. Canadian Respiratory Journal. 15: 159-65. PMID 18437259 DOI: 10.1155/2008/719231  0.258
2009 Sadatsafavi M, Marra CA, Ayas NT, Stradling J, Fleetham J. Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea. Sleep & Breathing = Schlaf & Atmung. 13: 241-52. PMID 19229577 DOI: 10.1007/S11325-009-0248-4  0.258
2012 Sadatsafavi M, Ganjizadeh S, Hatala R, Marra C, FitzGerald M. The "Lost NNT" can be used to represent uncertainty surrounding number needed to treat. Journal of Clinical Epidemiology. 65: 863-8. PMID 22652350 DOI: 10.1016/J.Jclinepi.2012.01.022  0.257
2005 Marra F, Marra CA, Moadebi S, Shi P, Elwood RK, Stark G, FitzGerald JM. Levofloxacin treatment of active tuberculosis and the risk of adverse events. Chest. 128: 1406-13. PMID 16162736 DOI: 10.1378/Chest.128.3.1406  0.256
2018 Loewen PS, Marra F, Marra CA. Influence of the Methods of Reporting Clinical Trial Results on Pharmacists' Willingness to Recommend Drug Therapy The Canadian Journal of Hospital Pharmacy. 52. DOI: 10.4212/Cjhp.V52I3.1796  0.255
2017 Duffull SB, Wright DFB, Marra CA, Anakin MG. A philosophical framework for pharmacy in the 21st century guided by ethical principles. Research in Social & Administrative Pharmacy : Rsap. PMID 28473230 DOI: 10.1016/J.Sapharm.2017.04.049  0.255
2006 Ayas NT, FitzGerald JM, Fleetham JA, White DP, Schulzer M, Ryan CF, Ghaeli R, Mercer GW, Cooper P, Tan MC, Marra CA. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Archives of Internal Medicine. 166: 977-84. PMID 16682570 DOI: 10.1001/Archinte.166.9.977  0.254
2001 Sinclair SE, Frighetto L, Loewen PS, Sunderji R, Teal P, Fagan SC, Marra CA. Cost-utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: A canadian healthcare perspective Pharmacoeconomics. 19: 927-936. PMID 11700779 DOI: 10.2165/00019053-200119090-00004  0.254
2014 Patel A, van der Kop M, Lester R, Ojakaa D, Igunza P, Gichuki R, Mahal D, Marra C. Health State Utility Values Of Hiv Infected Patients In Kenya Value in Health. 17: A279. DOI: 10.1016/J.Jval.2014.03.1624  0.254
2011 Davis JC, Marra CA, Robertson MC, Najafzadeh M, Liu-Ambrose T. Sustained economic benefits of resistance training in community-dwelling senior women. Journal of the American Geriatrics Society. 59: 1232-7. PMID 21718265 DOI: 10.1111/J.1532-5415.2011.03474.X  0.253
2007 Shalansky S, Jang L, Ignaszewski A, Clark C, Jung L, Marra C. Accuracy of a Prescription Claims Database for Medication Reconciliation for Outpatients with Heart Failure The Canadian Journal of Hospital Pharmacy. 60. DOI: 10.4212/Cjhp.V60I3.171  0.252
2000 Frighetto L, Marra CA, Stiver HG, Bryce EA, Jewesson PJ. Economic impact of standardized orders for antimicrobial prophylaxis program. The Annals of Pharmacotherapy. 34: 154-60. PMID 10676821 DOI: 10.1345/Aph.19142  0.251
2012 van der Kop ML, Karanja S, Thabane L, Marra C, Chung MH, Gelmon L, Kimani J, Lester RT. In-depth analysis of patient-clinician cell phone communication during the WelTel Kenya1 antiretroviral adherence trial. Plos One. 7: e46033. PMID 23049928 DOI: 10.1371/Journal.Pone.0046033  0.251
2007 Marra CA, Cibere J, Tsuyuki RT, Soon JA, Esdaile JM, Gastonguay L, Oteng B, Embley P, Colley L, Enenajor G, Kok R. Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. Arthritis and Rheumatism. 57: 1238-44. PMID 17907209 DOI: 10.1002/Art.23019  0.251
2000 Marra CA, Frighetto L, Quaia CB, de Lemos ML, Warkentin DI, Marra F, Jewesson PJ. A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis. Pharmacotherapy. 20: 931-40. PMID 10939554 DOI: 10.1592/Phco.20.11.931.35258  0.25
2014 Kopec J, Heath A, Sayre E, Cibere J, Li L, Marra C, Liu R, Esdaile J. THU0219 Prevalence of Joint Pain and Self-Reported Osteoarthritis in British Columbia, Canada Annals of the Rheumatic Diseases. 73: 257.3-258. DOI: 10.1136/Annrheumdis-2014-Eular.2300  0.25
2016 Hollander Z, Mohammadi T, Assadian S, Wilson-McManus J, Lam K, Ng R, McMaster W, Keown P, McManus B, Marra C. Cost-Effectiveness of a Blood-Based Biomarker Compared to Endomyocardial Biopsy for the Diagnosis of Acute Allograft Rejection The Journal of Heart and Lung Transplantation. 35: S53. DOI: 10.1016/J.Healun.2016.01.145  0.249
2018 van der Kop ML, Muhula S, Nagide PI, Thabane L, Gelmon L, Awiti PO, Abunah B, Kyomuhangi LB, Budd MA, Marra C, Patel A, Karanja S, Ojakaa DI, Mills EJ, Ekström AM, et al. Effect of an interactive text-messaging service on patient retention during the first year of HIV care in Kenya (WelTel Retain): an open-label, randomised parallel-group study. The Lancet. Public Health. PMID 29361433 DOI: 10.1016/S2468-2667(17)30239-6  0.249
2017 McCormick N, Marra CA, Aviña-Zubieta JA. Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases. Current Rheumatology Reports. 19: 72. PMID 29086172 DOI: 10.1007/S11926-017-0698-9  0.247
2012 Slobogean GP, Marra CA, Sadatsafavi M, Sanders DW. Is surgical fixation for stress-positive unstable ankle fractures cost effective? Results of a multicenter randomized control trial. Journal of Orthopaedic Trauma. 26: 652-8. PMID 22473067 DOI: 10.1097/Bot.0B013E31824Aec42  0.247
2014 Patel A, van der Kop M, Marra C, Ojakaa D, Igunza P, Lester R. Determinants Of Quality Of Life In Newly Diagnosed Hiv Infected Patients In Kenya Value in Health. 17: A280. DOI: 10.1016/J.Jval.2014.03.1629  0.247
2010 Guo N, Marra CA, Marra F. Responses to comments of Weis. Health and Quality of Life Outcomes. 8: 6. PMID 20074383 DOI: 10.1186/1477-7525-8-6  0.245
2019 Okada H, Johnston K, Nakayama T, Marra C, Tsuyuki RT. Economic Evaluation of Pharmacists Tackling the Burden of Hypertension in Japan. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11913. PMID 31607176 DOI: 10.1161/Hypertensionaha.119.13527  0.245
2017 O'Hara NN, Nophale LE, O'Hara LM, Marra CA, Spiegel JM. Tuberculosis testing for healthcare workers in South Africa: A health service analysis using Porter's Five Forces Framework International Journal of Healthcare Management. 10: 49-56. DOI: 10.1080/20479700.2016.1268814  0.245
2009 Davis J, Robertson M, Ashe M, Khan K, Marra C. PIH23 A SYSTEMATIC REVIEW OF THE COST OF FALLS IN OLDER ADULTS: AN INTERNATIONAL PERSPECTIVE Value in Health. 12: A166. DOI: 10.1016/S1098-3015(10)73891-2  0.245
2010 Davis JC, Robertson MC, Ashe MC, Liu-Ambrose T, Khan KM, Marra CA. Does a home-based strength and balance programme in people aged ≥80 years provide the best value for money to prevent falls? A systematic review of economic evaluations of falls prevention interventions British Journal of Sports Medicine. 44: 80-89. PMID 20154094 DOI: 10.1136/Bjsm.2008.060988  0.244
1999 Marra C. Book Review: Making Medical Decisions: An Approach to Clinical Decision Making for Practicing Physicians Annals of Pharmacotherapy. 33: 1128-1128. DOI: 10.1177/106002809903301001  0.244
2010 Johnston KM, Marra CA, Connors JM, Najafzadeh M, Sehn L, Peacock SJ. Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 13: 703-11. PMID 20561333 DOI: 10.1111/J.1524-4733.2010.00737.X  0.243
2004 Keown PA, Kiberd B, Balshaw R, Khorasheh S, Marra C, Belitsky P, Kalo Z. An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantation. Pharmacoeconomics. 22: 621-32. PMID 15244488 DOI: 10.2165/00019053-200422100-00001  0.243
2018 Frighetto L, Marra C, Gerber P, MacDougall C, Dolman J, Jewesson PJ. Addition of sevoflurane to the formulary: Impact on a surgical daycare unit The Canadian Journal of Hospital Pharmacy. 51. DOI: 10.4212/Cjhp.V51I4.1962  0.242
2010 Guo N, Marra F, Marra C, Elwood K, FitzGerald M. PRS34 EVALUATING PEOPLE'S PREFERENCES FOR PREVENTIVE TREATMENT OF LATENT TUBERCULOSIS INFECTION USING A DISCRETE CHOICE EXPERIMENT Value in Health. 13: A201-A202. DOI: 10.1016/S1098-3015(10)72987-9  0.241
2008 Woolcottj C, Khan K, Davis J, Buchanan J, Abu-Laban R, Marra C. PIH16 THE DIRECT COSTS OF INJURIOUS FALLS IN SENIORS Value in Health. 11: A250. DOI: 10.1016/S1098-3015(10)70789-0  0.241
2012 Hollander Z, Mohammadi T, Co M, Wilson-McManus J, Ng R, Balshaw R, McMaster R, Keown P, McManus B, Marra C. 427 Health Economic Evaluation of Predictive and Diagnostic Biomarkers of Acute Cardiac Rejection The Journal of Heart and Lung Transplantation. 31: S151. DOI: 10.1016/J.Healun.2012.01.437  0.24
2014 Zafari Z, Thorlund K, FitzGerald JM, Marra CA, Sadatsafavi M. Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes. Pharmacoeconomics. 32: 995-1004. PMID 24920194 DOI: 10.1007/S40273-014-0179-1  0.24
2018 McCormick N, Marra CA, Sadatsafavi M, Kopec JA, Aviña-Zubieta JA. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjogren's Syndrome: A General Population-Based Study. Arthritis Care & Research. PMID 29648677 DOI: 10.1002/Acr.23573  0.239
2013 Sadatsafavi M, Marra C, Bryan S. Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials. Health Economics. 22: 877-82. PMID 22933363 DOI: 10.1002/Hec.2869  0.239
2000 Gill NJ, Frighetto L, Marra C, Jewesson P. Patients’ Perceptions about Substitution of a Reference Drug while in Hospital: Focus on H2-Receptor Antagonists The Canadian Journal of Hospital Pharmacy. 53. DOI: 10.4212/Cjhp.V53I2.707  0.239
2015 Rosenthal M, Tsao NW, Tsuyuki RT, Marra CA. Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services. Research in Social & Administrative Pharmacy : Rsap. PMID 26050916 DOI: 10.1016/J.Sapharm.2015.05.003  0.238
2007 Sawatzky R, Liu-Ambrose T, Miller WC, Marra CA. Physical activity as a mediator of the impact of chronic conditions on quality of life in older adults. Health and Quality of Life Outcomes. 5: 68. PMID 18093310 DOI: 10.1186/1477-7525-5-68  0.238
2017 Kielly J, Davis EM, Marra C. Practice guidelines for pharmacists: The management of osteoarthritis. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 150: 156-168. PMID 28507652 DOI: 10.1177/1715163517702168  0.238
2012 Seto K, Marra F, Raymakers A, Marra CA. The cost effectiveness of human papillomavirus vaccines: a systematic review. Drugs. 72: 715-43. PMID 22413761 DOI: 10.2165/11599470-000000000-00000  0.237
2010 Liu-Ambrose TYL, Ashe MC, Marra C. Independent and inverse association of healthcare utilisation with physical activity in older adults with multiple chronic conditions British Journal of Sports Medicine. 44: 1024-1028. PMID 18487254 DOI: 10.1136/Bjsm.2008.046458  0.237
2013 Sadatsafavi M, Bansback N, Zafari Z, Najafzadeh M, Marra C. Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 16: 438-48. PMID 23538197 DOI: 10.1016/J.Jval.2012.10.018  0.235
2015 Levin D, Bell S, Sund R, Hartikainen SA, Tuomilehto J, Pukkala E, Keskimäki I, Badrick E, Renehan AG, Buchan IE, Bowker SL, Minhas-Sandhu JK, Zafari Z, Marra C, Johnson JA, et al. Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis. Diabetologia. 58: 493-504. PMID 25481707 DOI: 10.1007/S00125-014-3456-9  0.235
2010 Woolcott JC, Richardson KJ, Khan KM, Marra CA. Medication and Falls in Elderly Persons—Reply Jama Internal Medicine. 170: 834-835. DOI: 10.1001/Archinternmed.2010.123  0.233
2013 Davis JC, Bryan S, Marra CA, Sharma D, Chan A, Beattie BL, Graf P, Liu-Ambrose T. An economic evaluation of resistance training and aerobic training versus balance and toning exercises in older adults with mild cognitive impairment. Plos One. 8: e63031. PMID 23690976 DOI: 10.1371/Journal.Pone.0063031  0.232
2018 Donnan J, Marra C, Aubrey-Bassler K, Johnston K, Najafzadeh M, Swab M, Nguyen H, Gamble J. Patient Preferences Among Individuals with Type 2 Diabetes for Attributes of Diabetes Medications: A Discrete Choice Experiment Canadian Journal of Diabetes. 42: S9. DOI: 10.1016/J.Jcjd.2018.08.026  0.231
2020 Abdul Aziz YH, Heydon SJ, Duffull SB, Marra CA. What free services do pharmacists offer? Investigating the provision of unfunded pharmacy services in community pharmacies. Research in Social & Administrative Pharmacy : Rsap. PMID 32461164 DOI: 10.1016/J.Sapharm.2020.05.007  0.231
2007 Rowley AK, Resman-Targoff BH, Marra CA, Pucino F. Evolution of clinical pharmacy in the practice of rheumatology. The Annals of Pharmacotherapy. 41: 1705-7. PMID 17848418 DOI: 10.1345/Aph.1K275  0.23
2017 De Vera MA, Campbell NKJ, Chhina H, Galo JS, Marra C. Practical strategies and perceptions from community pharmacists following their experiences with conducting pharmacy practice research: a qualitative content analysis. The International Journal of Pharmacy Practice. PMID 29071805 DOI: 10.1111/Ijpp.12409  0.228
2003 Keown P, Balshaw R, Khorasheh S, Chong M, Marra C, Kalo Z, Korn A. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 17: 271-9. PMID 12899644 DOI: 10.2165/00063030-200317040-00006  0.226
2009 Regier DA, Ryan M, Phimister E, Marra CA. Bayesian and classical estimation of mixed logit: An application to genetic testing. Journal of Health Economics. 28: 598-610. PMID 19345433 DOI: 10.1016/J.Jhealeco.2008.11.003  0.226
2013 Colmers IN, Majumdar SR, Yasui Y, Bowker SL, Marra CA, Johnson JA. Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study. Diabetes Care. 36: 3070-5. PMID 23990517 DOI: 10.2337/Dc13-0045  0.226
2006 Tan M, Marra C. The cost of sleep disorders: no snoring matter. Sleep. 29: 282-3. PMID 16553012 DOI: 10.1093/Sleep/29.3.282  0.226
2018 Kielly J, Kelly DV, Hughes C, Day K, Hancock S, Asghari S, Gahagan J, Marra C, Nguyen H. Adaptation of POCT for pharmacies to reduce risk and optimize access to care in HIV, the APPROACH study protocol: examining acceptability and feasibility. Pilot and Feasibility Studies. 4: 59. PMID 30788134 DOI: 10.1186/S40814-018-0252-1  0.225
2002 Zed PJ, Loewen PS, Slavik RS, Marra CA. Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. The Annals of Pharmacotherapy. 35: 1528-34. PMID 11793613 DOI: 10.1345/Aph.1A028  0.223
2010 Sadatsafavi M, Shahidi N, Marra F, FitzGerald MJ, Elwood KR, Guo N, Marra CA. A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy. Journal of Clinical Epidemiology. 63: 257-69. PMID 19692208 DOI: 10.1016/J.Jclinepi.2009.04.008  0.223
2010 Davis JC, Marra CA, Beattie BL, Robertson MC, Najafzadeh M, Graf P, Nagamatsu LS, Liu-Ambrose T. Sustained cognitive and economic benefits of resistance training among community-dwelling senior women: a 1-year follow-up study of the Brain Power study. Archives of Internal Medicine. 170: 2036-8. PMID 21149764 DOI: 10.1001/Archinternmed.2010.462  0.222
2020 Ndukwe HC, Shaul D, Shin J, Pang CD, Swee CY, Hong BT, Dummer JF, Fitzgerald C, Wilby KJ, Marra CA. Assessment of inhaler technique among fourth-year pharmacy students: Implications for the use of entrustable professional activities. Currents in Pharmacy Teaching & Learning. 12: 281-286. PMID 32273063 DOI: 10.1016/J.Cptl.2019.12.001  0.221
2018 Marra C, Nimmo CR, Jewesson P. A prospective survey of knowledge and perceptions of ondansetron: what do health care workers know about this drug? The Canadian Journal of Hospital Pharmacy. 48: 336. DOI: 10.4212/Cjhp.V48I6.2337  0.221
2009 Makela NL, Birch PH, Friedman JM, Marra CA. Parental perceived value of a diagnosis for intellectual disability (ID): a qualitative comparison of families with and without a diagnosis for their child's ID. American Journal of Medical Genetics. Part A. 149: 2393-402. PMID 19842198 DOI: 10.1002/Ajmg.A.33050  0.22
1997 Frighetto L, Marra CA, Jewesson PJ. Tracking and reporting drug expenditures. American Journal of Health-System Pharmacy. 54: 2302-2306. PMID 9347103 DOI: 10.1093/Ajhp/54.20.2302  0.22
2019 Abdul Aziz Y, Heydon S, Duffull S, Marra C. How do pharmacists contribute to the compassionate budget? An investigation of unfunded pharmacy services Research in Social and Administrative Pharmacy. 15: e7-e8. DOI: 10.1016/J.Sapharm.2019.03.085  0.219
2006 Wang CS, Ko HH, Yoshida EM, Marra CA, Richardson K. Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 6: 1586-99. PMID 16827859 DOI: 10.1111/J.1600-6143.2006.01362.X  0.219
2012 Marra CA, Cibere J, Grubisic M, Grindrod KA, Gastonguay L, Thomas JM, Embley P, Colley L, Tsuyuki RT, Khan KM, Esdaile JM. Pharmacist-initiated intervention trial in osteoarthritis: a multidisciplinary intervention for knee osteoarthritis. Arthritis Care & Research. 64: 1837-45. PMID 22930542 DOI: 10.1002/Acr.21763  0.216
2007 Regier D, Marra C, Ryan M. MC3 THE DEVELOPMENT OF AN INCREMENTAL WILLINGNESS TO PAY CURVE DERIVED FROM A DISCRETE CHOICE EXPERIMENT Value in Health. 10: A224. DOI: 10.1016/S1098-3015(10)64864-4  0.212
2011 Johnson JA, Bowker SL, Richardson K, Marra CA. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia. 54: 2263-71. PMID 21748485 DOI: 10.1007/S00125-011-2242-1  0.212
2009 Marra C, Ogilvie G, Gastonguay L, Colley L, Taylor D, Marra F. Patients with genital warts have a decreased quality of life. Sexually Transmitted Diseases. 36: 258-60. PMID 19265737 DOI: 10.1097/Olq.0B013E318191A55E  0.211
2019 Donnan JR, Grandy CA, Chibrikov E, Marra CA, Aubrey-Bassler K, Johnston K, Swab M, Hache J, Curnew D, Nguyen H, Gamble JM. Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis. Bmj Open. 9: e022577. PMID 30813108 DOI: 10.1136/Bmjopen-2018-022577  0.211
2006 Ayas NT, Marra C. Continuous positive airway pressure therapy for obstructive sleep apnea syndrome: do the dollars make sense? Sleep. 28: 1211-3. PMID 16295201 DOI: 10.1093/Sleep/28.10.1211  0.209
2011 Wang M, Fitzgerald JM, Richardson K, Marra CA, Cook VJ, Hajek J, Elwood RK, Bowie WR, Marra F. Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic? The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 15: 1062-8. PMID 21740669 DOI: 10.5588/Ijtld.10.0734  0.209
2007 Mulgrew AT, Ryan CF, Fleetham JA, Cheema R, Fox N, Koehoorn M, Fitzgerald JM, Marra C, Ayas NT. The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Sleep Medicine. 9: 42-53. PMID 17825611 DOI: 10.1016/J.Sleep.2007.01.009  0.207
2011 Ayas NT, Pack A, Marra C. The demise of portable monitoring to diagnose OSA? not so fast! Sleep. 34: 691-692. PMID 21629355 DOI: 10.5665/Sleep.1026  0.206
2014 Patel A, Marra C, Lalji F, Law M, Lester R. The Impact Of Pharmacist-Delivered Vaccination On Influenza Immunization Rates And Perception In Canada: An Ecological Study Value in Health. 17: A148. DOI: 10.1016/J.Jval.2014.03.861  0.206
2007 Marra C, Sullivan S, Najafzadeh M, Sadatsafavi M, Jones P, Aaron S, FitzGerald J. PRS12 MAPPING THE EQ-5D FROM THE ST. GEORGE'S RESPIRATORY QUESTIONNAIRE IN A CLINICAL TRIAL OF COPD TREATMENTS—RESULTS FROM THE OPTIMAL TRIAL Value in Health. 10: A310. DOI: 10.1016/S1098-3015(10)65122-4  0.203
2013 Marra F, Young F, Richardson K, Marra CA. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events. Influenza and Other Respiratory Viruses. 7: 584-603. PMID 22974174 DOI: 10.1111/Irv.12000  0.201
2000 Loewen PS, Marra CA, Zed PJ. 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomiting Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie. 47: 1008-1018. PMID 11032279 DOI: 10.1007/Bf03024875  0.2
2003 Marra F, Marra CA, Stiver HG. A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection. Canadian Respiratory Journal. 10: 381-8. PMID 14571290 DOI: 10.1155/2003/453183  0.199
2011 Bowker SL, Richardson K, Marra CA, Johnson JA. Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women. Diabetes Care. 34: 2542-4. PMID 21972408 DOI: 10.2337/Dc11-1199  0.198
2019 Marra CA, Houle SK, Green JA. Are entry year pharmacy students created equally? A comparison between New Zealand and Canada Research in Social and Administrative Pharmacy. 15: e23. DOI: 10.1016/J.Sapharm.2019.03.136  0.198
1996 Marra CA, Shalansky KF. Ampicillin-Induced Maculopapular versus Urticarial Rash Annals of Pharmacotherapy. 30: 401-402. PMID 8729896 DOI: 10.1177/106002809603000414  0.194
2016 Raymakers AJ, Tsao NW, Marra CA, Clements PJ, Khanna D. Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association? The Journal of Rheumatology. PMID 27481898 DOI: 10.3899/jrheum.160162  0.176
2009 Fitzgerald JM, Marra C. The challenge of making cost-effective asthma therapy available International Journal of Tuberculosis and Lung Disease. 13: 545. PMID 19383181  0.174
2023 Price E, Shirtcliffe A, Fisher T, Chadwick M, Marra CA. A systematic review of economic evaluations of pharmacist services. The International Journal of Pharmacy Practice. PMID 37543960 DOI: 10.1093/ijpp/riad052  0.17
2021 Cousins K, Norris P, Horsburgh S, Smith A, Keown S, Samaranayaka A, Marra C, Churchward M. Impact of removing prescription charges on health outcomes: protocol for a randomised controlled trial. Bmj Open. 11: e049261. PMID 34301661 DOI: 10.1136/bmjopen-2021-049261  0.169
2020 Chan SJ, Yeo HY, Stamp LK, Treharne GJ, Marra CA. What Are the Preferences of Patients With Rheumatoid Arthritis for Treatment Modification? A Scoping Review. The Patient. PMID 33336324 DOI: 10.1007/s40271-020-00488-7  0.168
2021 Raghunandan R, Marra CA, Tordoff J, Smith A. Examining non-medical prescribing trends in New Zealand: 2016-2020. Bmc Health Services Research. 21: 418. PMID 33941188 DOI: 10.1186/s12913-021-06435-y  0.154
2021 Raghunandan R, Howard K, Marra CA, Tordoff J, Smith A. Identifying New Zealand Public Preferences for Pharmacist Prescribers in Primary Care: A Discrete Choice Experiment. The Patient. PMID 34109570 DOI: 10.1007/s40271-021-00529-9  0.148
2023 Darlow B, Brown M, Stanley J, Abbott JH, Briggs AM, Clark J, Frew G, Grainger R, Hood F, Hudson B, Keenan R, Marra C, McKinlay E, Pask A, Pierobon A, et al. Reducing the burden of knee osteoarthritis through community pharmacy: Protocol for a randomised controlled trial of the Knee Care for Arthritis through Pharmacy Service. Musculoskeletal Care. PMID 37212721 DOI: 10.1002/msc.1785  0.144
2019 Al Hamarneh YN, Johnston K, Marra CA, Tsuyuki RT. Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the REACH study. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 152: 257-266. PMID 31320960 DOI: 10.1177/1715163519851822  0.143
2016 O'Hara NN, Slobogean GP, Mohammadi T, Marra CA, Vicente MR, Khakban A, McKee MD. Are patients willing to pay for total shoulder arthroplasty? Evidence from a discrete choice experiment. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 59: 107-12. PMID 27007091 DOI: 10.1503/cjs.011915  0.142
2023 Norris P, Cousins K, Horsburgh S, Keown S, Churchward M, Samaranayaka A, Smith A, Marra C. Impact of removing prescription co-payments on the use of costly health services: a pragmatic randomised controlled trial. Bmc Health Services Research. 23: 31. PMID 36641460 DOI: 10.1186/s12913-022-09011-0  0.141
2022 Nind J, Smith A, Scahill S, Marra CA. A Systematic Review of Independent and Chain Pharmacies Effects on Medication Adherence. Pharmacy (Basel, Switzerland). 10. PMID 36287445 DOI: 10.3390/pharmacy10050124  0.137
2002 Cook TF, Frighetto L, Marra CA, Jewesson PJ. Patterns of use and patients' attitudes toward complementary medications: a survey of adult general medicine patients at a major Canadian teaching hospital. The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique. 9: 183-9. PMID 12584576  0.133
2017 Trenaman L, Boonen A, Guillemin F, Hiligsmann M, Hoens A, Marra C, Taylor W, Barton J, Tugwell P, Wells G, Bansback N. OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients? The Journal of Rheumatology. PMID 28298567 DOI: 10.3899/jrheum.161112  0.13
2023 Nind J, Marra CA, Scahill S, Smith A. Describing the consumer profile of different types of community pharmacy in Aotearoa New Zealand. Journal of Primary Health Care. 15: 376-381. PMID 38112697 DOI: 10.1071/HC23083  0.129
2023 Dixon DL, Johnston K, Patterson J, Marra CA, Tsuyuki RT. Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States. Jama Network Open. 6: e2341408. PMID 37921763 DOI: 10.1001/jamanetworkopen.2023.41408  0.127
2020 Raghunandan R, Howard K, Marra CA, Tordoff J, Smith A. Identifying Community Pharmacist Preferences For Prescribing Services in Primary Care in New Zealand: A Discrete Choice Experiment. Applied Health Economics and Health Policy. PMID 33073328 DOI: 10.1007/s40258-020-00615-3  0.127
2023 Yeo HY, Wong JHY, Chan SJ, Latu ATF, Han CH, Anwar M, Marra CA. Exploring the Important Determinants Shaping Treatment Preferences: Qualitative Insights into Breast Cancer Patient Experiences and Perspectives in New Zealand. Patient Preference and Adherence. 17: 3525-3537. PMID 38148974 DOI: 10.2147/PPA.S443217  0.124
2022 Abdul Aziz YH, Heydon SJ, Duffull SB, Marra CA. Investigating the provision, nature and associated costs of unfunded pharmacy services: A nationwide study. Research in Social & Administrative Pharmacy : Rsap. PMID 36127239 DOI: 10.1016/j.sapharm.2022.08.019  0.12
2021 Al Hamarneh YN, Marra C, Gniadecki R, Keeling S, Morgan A, Tsuyuki R. RIALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre-post intervention study. Bmj Open. 11: e043612. PMID 33762234 DOI: 10.1136/bmjopen-2020-043612  0.118
2023 Norris P, Cousins K, Horsburgh S, Keown S, Churchward M, Samaranayaka A, Smith A, Marra C. Correction: Impact of removing prescription co-payments on the use of costly health services: a pragmatic randomised controlled trial. Bmc Health Services Research. 23: 243. PMID 36927482 DOI: 10.1186/s12913-023-09251-8  0.115
2020 Marra CA, Khakban A, Wilby KJ, Buckham RB, Anakin M. Using Best-Worst Choice Methodology in a Survey of Pharmacists Regarding Pharmacy Practice Skills Teaching. American Journal of Pharmaceutical Education. 84: 848015. PMID 34283781 DOI: 10.5688/ajpe848015  0.115
2023 Abdul Aziz YH, Heydon SJ, Duffull SB, Marra CA. What do pharmacy users think of free pharmacy services? Investigating pharmacy users' perceptions, attitudes and willingness to pay for free healthcare from pharmacies. Exploratory Research in Clinical and Social Pharmacy. 11: 100288. PMID 37408842 DOI: 10.1016/j.rcsop.2023.100288  0.113
2004 Frighetto L, Marra C, Bandali S, Wilbur K, Naumann T, Jewesson P. An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients. Health and Quality of Life Outcomes. 2: 17. PMID 15040803 DOI: 10.1186/1477-7525-2-17  0.107
2023 Yeo HY, Liew AC, Chan SJ, Anwar M, Han CH, Marra CA. Understanding Patient Preferences Regarding the Important Determinants of Breast Cancer Treatment: A Narrative Scoping Review. Patient Preference and Adherence. 17: 2679-2706. PMID 37927344 DOI: 10.2147/PPA.S432821  0.104
2015 Davis JC, Bryan S, Marra CA, Hsiung GYR, Liu-Ambrose T. Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia British Journal of Sports Medicine. 49: 1343-1347. DOI: 10.1136/bjsports-2013-092743  0.103
2023 Rangi P, Marra C, Scahill S, Anwar M. Impact of Promotional Videos on Public Perception of Pharmacy Services. Journal of Pharmacy Practice. 8971900231177201. PMID 37192543 DOI: 10.1177/08971900231177201  0.098
2017 Alwashmi M, Hawboldt J, Davis E, Marra C, Gamble J, AbuAshour W. The Effect of Smartphone Interventions on Patients With Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review and Meta-Analysis Iproceedings. 3: e6. DOI: 10.2196/iproc.8358  0.098
2021 Aziz YHA, Heydon SJ, Duffull SB, Marra CA. Are professional pharmacy services being offered for free in pharmacies? A feasibility study exploring the use of a time motion study in New Zealand. Pharmacy Practice. 19: 2422. PMID 34457095 DOI: 10.18549/PharmPract.2021.3.2422  0.097
2015 Khan KM, Windt A, Davis JC, Dawes M, Liu-Ambrose T, Madden K, Marra CA, Housden L, Hoppmann C, Adams DJ. Group Medical Visits (GMVs) in primary care: An RCT of group-based versus individual appointments to reduce HbA1c in older people Bmj Open. 5. DOI: 10.1136/bmjopen-2014-007441  0.094
2021 Dresser J, Barazanchi A, Meldrum A, Marra C, Wilby KJ. Identifying perceptions and themed learning outcomes between pharmacy and dentistry students through interprofessional education and collaboration in the dental clinic. Currents in Pharmacy Teaching & Learning. 13: 843-847. PMID 34074516 DOI: 10.1016/j.cptl.2021.03.012  0.09
2022 Darlow B, Brown M, Hudson B, Frew G, Clark J, Vincent L, Grainger R, Marra C, McKinlay E, Abbott JH, Briggs AM. Knee osteoarthritis and the knowledgeable, trustworthy pharmacist: Patient and pharmacist perceptions of community pharmacy-based education and support. Musculoskeletal Care. PMID 35615979 DOI: 10.1002/msc.1660  0.089
2009 Grindrod K, Marra C, Colley L, Oteng B, Gastonguay L, Tsuyuki R. What Patients Do Following a New Diagnosis of Knee Osteoarthritis Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada. 142: 43-43. DOI: 10.3821/1913-701X-142.1.43  0.083
2022 Darlow B, Brown M, Hudson B, Frew G, Clark J, Vincent L, Abbott JH, Briggs AM, Grainger R, Marra C, McKinlay E, Stanley J. Feasibility of a randomised controlled trial of two types of written information for people with knee osteoarthritis. Osteoarthritis and Cartilage Open. 4: 100254. PMID 36475283 DOI: 10.1016/j.ocarto.2022.100254  0.083
2021 Kopec JA, Heath AJ, Sayre EC, Cibere J, Li LC, Marra CA, Liu RR, Esdaile JM. Prevalence of joint-specific osteoarthritis and joint pain in British Columbia, Canada. Rheumatology International. PMID 34716488 DOI: 10.1007/s00296-021-05031-x  0.076
2023 Wilby KJ, Smith SA, Yee I, Cannon F, Kim J, Cha DJ, Atiquzzaman M, Marra C. Messaging preferences for the role of pharmacists in pharmacy education recruitment material. Currents in Pharmacy Teaching & Learning. PMID 37355384 DOI: 10.1016/j.cptl.2023.06.008  0.074
2015 Rosenthal M, Tsao NW, Tsuyuki RT, Marra CA. Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services Research in Social and Administrative Pharmacy. DOI: 10.1016/j.sapharm.2015.05.003  0.071
2022 Marra CA, Donat I, Lee M, Roberti H, Sue T, Au M, Lam D, Wilby KJ. Pharmacy postgraduate education transformation: pharmacist preferences for microcredentials. The International Journal of Pharmacy Practice. PMID 36047515 DOI: 10.1093/ijpp/riac065  0.066
2007 Regier DA, Marra CA. Self-managed oral anticoagulation therapy Canadian Medical Association Journal. 176: 813-814. DOI: 10.1503/cmaj.1060232  0.061
2023 Nair D, Green JA, Houle SKD, Marra CA. Do entry year pharmacy students have similar personal characteristics? Comparing personalities, professional goals, and role perceptions. Research in Social & Administrative Pharmacy : Rsap. PMID 36702707 DOI: 10.1016/j.sapharm.2023.01.001  0.06
2010 Marra F, Kaczorowski JA, Marra C. Assessing Pharmacists' Attitudes regarding Delivery of the Pandemic Influenza Vaccine in British Columbia Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada. 143: 278-284. DOI: 10.3821/1913-701X-143.6.278  0.049
2011 Marra F, Marra C, Elwood K. In reply The International Journal of Tuberculosis and Lung Disease. 15: 1560-1560. DOI: 10.5588/ijtld.11.0515-2  0.01
Hide low-probability matches.